Alt5 Sigma Secures $1.5B Funding from Point72 and ExodusPoint

Alt5 Sigma, a biotech-turned-crypto payments firm, has secured a significant $1.5 billion funding round. The investment was led by hedge funds Point72 Asset Management and ExodusPoint Capital Management, signaling a shift in institutional interest towards regulated crypto infrastructure rather than speculative tokens. This landmark funding brings Alt5 Sigma closer to its goal of providing comprehensive digital asset services for enterprise clients. Wall Street’s entry into the sector marks a significant milestone as it showcases a growing acceptance of blockchain solutions within the traditional financial ecosystem.